ARS Pharmaceuticals launched Neffy, the first FDA-approved needle-free epinephrine nasal spray for severe allergic reactions.

A YOUNG man tragically died from an asthma attack after the cost of his inhaler skyrocketed from $66 to $500, according to a lawsuit filed by his family. Cole Schmidtknecht, 22, had battled ...

Improving inhaler adherence is crucial, especially during winter when asthma symptoms can worsen. The first step is ensuring ...

Undoubtedly there exists a need to improve the care of and outcomes for children who are suffering from asthma. This blog ...

The short answer is no, you cannot outgrow asthma, but your symptoms may be less severe. Learn when asthma goes into ...

Kinaset Therapeutics, a clinical-stage biopharmaceutical company developing inhaled therapeutics to treat serious respiratory ...

COPD-asthma-devices-market2025 PORTLAND, DE, UNITED STATES, January 29, 2025 /EINPresswire / -- Day-to-day exposure to environmental pollutio ...

Ian McKnight is researching the biological mechanisms underlying allergies, with the goal of developing new therapeutics to ...

GSK plc (LSE/NYSE: GSK) today announced that the European Medicines Agency has accepted for review the Marketing Authorisation Application for the use of depemokimab in two indications. The submitted ...

These coverings, particularly over their mouth and nose, warms the air a little before it enters their system, warding off ...